数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Feike Sijbesma Chairman, Director 64 20.63万 未持股 2024-02-20
David Pyott Director 71 15.23万 未持股 2024-02-20
Peter Loscher Director 66 15.68万 未持股 2024-02-20
Herna Verhagen Director 58 12.13万 未持股 2024-02-20
Paul Stoffels -- Director 62 17.73万 未持股 2024-02-20
Marc Harrison -- Director 60 12.63万 未持股 2024-02-20
蔡淑君 Director 66 14.03万 未持股 2024-02-20
Indra Nooyi -- Director 69 13.13万 未持股 2024-02-20
Liz Doherty Director 67 未披露 未持股 2024-02-20
Sanjay Poonen Director 54 13.53万 未持股 2024-02-20

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Marnix van Ginneken Executive Vice President 51 141.68万 未持股 2024-02-20
Abhijit Bhattacharya Executive Vice President 63 189.61万 未持股 2024-02-20
Andy Ho -- Executive Vice President,Chief Market Leader of Philips Greater China 63 未披露 未持股 2024-02-20
Roy Jakobs Chief Executive Officer 50 44.47万 未持股 2024-02-20
Bert van Meurs -- Executive Vice President,Chief Business Leader Image Guided Therapy and Chief Business Leader Precision Diagnosis , responsible for Diagnosis & Treatment 63 未披露 未持股 2024-02-20
Deeptha Khanna -- Executive Vice President,Chief Business Leader Personal Health 49 未披露 未持股 2024-02-20
Edwin Paalvast -- Executive Vice President,Chief Market Leader of International Region 62 未披露 未持股 2024-02-20
Shez Partovi -- Executive Vice President,Chief Innovation & Strategy Officer 58 未披露 未持股 2024-02-20
Willem Appelo -- Executive Vice President,Chief Operations Officer 61 未披露 未持股 2024-02-20
Jeff DiLullo -- Executive Vice President,Chief Market Leader of Philips North America 55 未披露 未持股 2024-02-20
Heidi Sichien -- Executive Vice President,Chief People Officer 50 未披露 未持股 2024-02-20
Steve C de Baca -- Executive Vice President,Chief Patient Safety and Quality Officer 56 未披露 未持股 2024-02-20
Julia Strandberg -- Executive Vice President,Chief Business Leader Connected Care 50 未披露 未持股 2024-02-20

董事简历

中英对照 |  中文 |  英文
Feike Sijbesma

Feike Sijbesma,荷兰国籍(男),于2014年11月被任命为委员会成员,涉及企业、责任、提名和公司治理(主席)。他目前任职Royal DSM N.V。(担任首席执行官兼管理委员会的主席)、De Nederlandsche Bank(监事会成员)、CEFIC (欧洲化学委员会)、CEFIC(欧洲化学委员会)。此前,他曾任职DSM Netherlands的监事会(担任主席)、Dutch Genomics Initiative (NGI)(成员)、Utrecht University (董事会成员)、Dutch Cancer Institute (NKI/AVL) (董事会成员)。


Feike Sijbesma,Former CEO of Koninklijke DSM NV (Honorary Chairman) and former non-executive Director of Unilever NV. Co-Chair of the Global Climate Adaptation Center and Member of the Board of Trustees of the World Economic Forum.
Feike Sijbesma,荷兰国籍(男),于2014年11月被任命为委员会成员,涉及企业、责任、提名和公司治理(主席)。他目前任职Royal DSM N.V。(担任首席执行官兼管理委员会的主席)、De Nederlandsche Bank(监事会成员)、CEFIC (欧洲化学委员会)、CEFIC(欧洲化学委员会)。此前,他曾任职DSM Netherlands的监事会(担任主席)、Dutch Genomics Initiative (NGI)(成员)、Utrecht University (董事会成员)、Dutch Cancer Institute (NKI/AVL) (董事会成员)。
Feike Sijbesma,Former CEO of Koninklijke DSM NV (Honorary Chairman) and former non-executive Director of Unilever NV. Co-Chair of the Global Climate Adaptation Center and Member of the Board of Trustees of the World Economic Forum.
David Pyott

David Pyott,Allergan公司的前任主席(2001年至2015年)、首席执行官(1998年至2015年)、Avery Dennison Corporation的现任董事(1999年以来)、其首席独立董事(2010年以来)、Alnylam Pharmaceuticals公司、BioMarin Pharmaceutical公司的董事会成员、Chapman University监事会的成员、Ophthalmology Foundation的理事会成员、the Foundation of the American Academy of Ophthalmology的咨询委员会的成员。


David Pyott,Former Chairman and Chief Executive Officer of Allergan, Inc. and former Lead Director of Avery Dennison Corporation. Currently member of the Board of Directors of Alnylam Pharmaceuticals Inc., BioMarin Pharmaceutical Inc. and Pliant Therapeutics. Chairman of the Governing Board of London Business School, member of the Board of Trustees and Executive Committee of the California Institute of Technology, Vice President of the Ophthalmology Foundation and President of the Advisory Board of the Foundation of the American Academy of Ophthalmology.
David Pyott,Allergan公司的前任主席(2001年至2015年)、首席执行官(1998年至2015年)、Avery Dennison Corporation的现任董事(1999年以来)、其首席独立董事(2010年以来)、Alnylam Pharmaceuticals公司、BioMarin Pharmaceutical公司的董事会成员、Chapman University监事会的成员、Ophthalmology Foundation的理事会成员、the Foundation of the American Academy of Ophthalmology的咨询委员会的成员。
David Pyott,Former Chairman and Chief Executive Officer of Allergan, Inc. and former Lead Director of Avery Dennison Corporation. Currently member of the Board of Directors of Alnylam Pharmaceuticals Inc., BioMarin Pharmaceutical Inc. and Pliant Therapeutics. Chairman of the Governing Board of London Business School, member of the Board of Trustees and Executive Committee of the California Institute of Technology, Vice President of the Ophthalmology Foundation and President of the Advisory Board of the Foundation of the American Academy of Ophthalmology.
Peter Loscher

Peter Loscher,生于奥地利,他是Telefonica, S.A.的董事。Loscher先生是全球人类健康的总裁,Merck & Co.的执行董事会成员,GE Healthcare Bio - Sciences的首席执行官,GE公司执行委员会成员。他也是Amersham Plc的首席运营官和董事会成员。他曾担任Aventis and Hoeschst的高级领导职务。Loscher先生是奥地利OMV AG的前监事会主席。从2014年到2016年,他担任Renova Management AG的首席执行官。过去,他还曾担任德意志银行监事会成员、西门子公司董事长兼首席执行官等。目前,Loscher先生是Sulzer AG的董事会主席,Thyssen-Bornemisza Group AG(瑞士)的董事会成员,以及Doha Venture Capital LLC(卡塔尔)的非执行董事。他还是上海同济大学名誉教授,曾获奥地利共和国黄金大荣誉勋章、俄罗斯联邦友谊勋章、西班牙公民勋章骑士指挥官。Loscher先生在维也纳经济大学(Vienna University of Economics)学习经济学,并在那里获得工商管理硕士学位,在香港中文大学(Chinese University of Hong Kong)学习商业。他在哈佛商学院(Harvard Business School)完成了高级管理课程AMP,并获得了密歇根州立大学(Michigan State University)的荣誉工程博士学位,同时也是布拉迪斯拉发斯洛伐克工程大学(slovaluniversalofengineering)的荣誉博士学位。


Peter Loscher,Former President and CEO of Siemens AG, President of Global Human Health and Member of the Executive Board of Merck & Co., President and CEO of GE Healthcare Bio-Sciences and member of GE's Corporate Executive Council, CEO and Delegate of the Board of Directors of Renova Management AG. Currently member of the Board of Directors of Telefónica S.A. and CaixaBank S.A. and Chairman of the Supervisory Board of Telefónica Deutschland Holding AG, Non-Executive Director of Thyssen-Bornemisza Group AG and Doha Venture Capital LLC.
Peter Loscher,生于奥地利,他是Telefonica, S.A.的董事。Loscher先生是全球人类健康的总裁,Merck & Co.的执行董事会成员,GE Healthcare Bio - Sciences的首席执行官,GE公司执行委员会成员。他也是Amersham Plc的首席运营官和董事会成员。他曾担任Aventis and Hoeschst的高级领导职务。Loscher先生是奥地利OMV AG的前监事会主席。从2014年到2016年,他担任Renova Management AG的首席执行官。过去,他还曾担任德意志银行监事会成员、西门子公司董事长兼首席执行官等。目前,Loscher先生是Sulzer AG的董事会主席,Thyssen-Bornemisza Group AG(瑞士)的董事会成员,以及Doha Venture Capital LLC(卡塔尔)的非执行董事。他还是上海同济大学名誉教授,曾获奥地利共和国黄金大荣誉勋章、俄罗斯联邦友谊勋章、西班牙公民勋章骑士指挥官。Loscher先生在维也纳经济大学(Vienna University of Economics)学习经济学,并在那里获得工商管理硕士学位,在香港中文大学(Chinese University of Hong Kong)学习商业。他在哈佛商学院(Harvard Business School)完成了高级管理课程AMP,并获得了密歇根州立大学(Michigan State University)的荣誉工程博士学位,同时也是布拉迪斯拉发斯洛伐克工程大学(slovaluniversalofengineering)的荣誉博士学位。
Peter Loscher,Former President and CEO of Siemens AG, President of Global Human Health and Member of the Executive Board of Merck & Co., President and CEO of GE Healthcare Bio-Sciences and member of GE's Corporate Executive Council, CEO and Delegate of the Board of Directors of Renova Management AG. Currently member of the Board of Directors of Telefónica S.A. and CaixaBank S.A. and Chairman of the Supervisory Board of Telefónica Deutschland Holding AG, Non-Executive Director of Thyssen-Bornemisza Group AG and Doha Venture Capital LLC.
Herna Verhagen

Herna Verhagen,荷兰国际监督者委员会的成员,提名委员会和HeTractGeBouw NV的赞助委员会,GooSkMeM丁基金会顾问委员会成员和VNO-NCW董事会成员。


Herna Verhagen,Currently CEO of PostNL, member of the Supervisory Board of ING Groep N.V., member of the Supervisory Board of Het Concertgebouw N.V. and member of the Advisory Board of Goldschmeding Foundation.
Herna Verhagen,荷兰国际监督者委员会的成员,提名委员会和HeTractGeBouw NV的赞助委员会,GooSkMeM丁基金会顾问委员会成员和VNO-NCW董事会成员。
Herna Verhagen,Currently CEO of PostNL, member of the Supervisory Board of ING Groep N.V., member of the Supervisory Board of Het Concertgebouw N.V. and member of the Advisory Board of Goldschmeding Foundation.
Paul Stoffels

Paul Stoffels,1962年出生于比利时。自2018年起担任监事会成员;第一任期于2022年届满。现任强生执行委员会副主席兼首席科学官。此前,曾任强生全球制药部主席、Virco首席执行官和Tibotec董事长。


Paul Stoffels,Former CEO of Virco, Chairman of Tibotec, worldwide Chair of Pharmaceuticals at Johnson & Johnson and Chief Scientific Officer & member of the Executive Committee at Johnson & Johnson. Currently CEO and Chairman of the Board of Directors of Galapagos NV.
Paul Stoffels,1962年出生于比利时。自2018年起担任监事会成员;第一任期于2022年届满。现任强生执行委员会副主席兼首席科学官。此前,曾任强生全球制药部主席、Virco首席执行官和Tibotec董事长。
Paul Stoffels,Former CEO of Virco, Chairman of Tibotec, worldwide Chair of Pharmaceuticals at Johnson & Johnson and Chief Scientific Officer & member of the Executive Committee at Johnson & Johnson. Currently CEO and Chairman of the Board of Directors of Galapagos NV.
Marc Harrison

Marc Harrison,自2018年起担任监事会成员;第一届任期于2022年届满。现任Intermountain 医疗保健公司总裁兼首席执行官。克利夫兰诊所前国际业务发展主管和克利夫兰诊所阿布扎比首席执行官。


Marc Harrison,Former President and Chief Executive Officer of Intermountain Healthcare and former Chief of International Business Development for Cleveland Clinic and Chief Executive Officer of Cleveland Clinic Abu Dhabi. Currently CEO HATCo (Health Assurance Transformation Corporation) at General Catalyst.
Marc Harrison,自2018年起担任监事会成员;第一届任期于2022年届满。现任Intermountain 医疗保健公司总裁兼首席执行官。克利夫兰诊所前国际业务发展主管和克利夫兰诊所阿布扎比首席执行官。
Marc Harrison,Former President and Chief Executive Officer of Intermountain Healthcare and former Chief of International Business Development for Cleveland Clinic and Chief Executive Officer of Cleveland Clinic Abu Dhabi. Currently CEO HATCo (Health Assurance Transformation Corporation) at General Catalyst.
蔡淑君

蔡淑君,新加坡电信有限公司前集团首席执行官,任Prudential plc、Bharti Airtel Limited、Bharti Telecom Limited和Ayala Corporation董事会成员。新加坡总统顾问委员会成员,新加坡公共服务委员会副主席。


Chua Sock Koong,Former Group CEO of Singapore Telecommunications Limited and member of the Board of Directors of Prudential plc, Bharti Airtel Limited, Bharti Telecom Limited and Ayala Corporation. Member of the Council of Presidential Advisors of Singapore, Deputy Chairman of the Public Service Commission of Singapore.
蔡淑君,新加坡电信有限公司前集团首席执行官,任Prudential plc、Bharti Airtel Limited、Bharti Telecom Limited和Ayala Corporation董事会成员。新加坡总统顾问委员会成员,新加坡公共服务委员会副主席。
Chua Sock Koong,Former Group CEO of Singapore Telecommunications Limited and member of the Board of Directors of Prudential plc, Bharti Airtel Limited, Bharti Telecom Limited and Ayala Corporation. Member of the Council of Presidential Advisors of Singapore, Deputy Chairman of the Public Service Commission of Singapore.
Indra Nooyi

Indra Nooyi,1955年出生,美国人。自2021年起担任监事会成员;第一届任期于2025年届满。百事可乐前首席财务官兼董事长兼首席执行官。现任亚马逊公司董事会成员和审计委员会主席。淡马锡国际顾问委员会成员,麻省理工学院董事会和执行委员会成员。


Indra Nooyi,Former CFO, President, Chairman and CEO of PepsiCo. Currently member of the Board of Directors and Chair of the Audit Committee of Amazon, Inc. Member of the International Board of Advisors of Temasek, member of the Board of Trustees of the Memorial Sloan Kettering Hospital, trustee of the national gallery of art.
Indra Nooyi,1955年出生,美国人。自2021年起担任监事会成员;第一届任期于2025年届满。百事可乐前首席财务官兼董事长兼首席执行官。现任亚马逊公司董事会成员和审计委员会主席。淡马锡国际顾问委员会成员,麻省理工学院董事会和执行委员会成员。
Indra Nooyi,Former CFO, President, Chairman and CEO of PepsiCo. Currently member of the Board of Directors and Chair of the Audit Committee of Amazon, Inc. Member of the International Board of Advisors of Temasek, member of the Board of Trustees of the Memorial Sloan Kettering Hospital, trustee of the national gallery of art.
Liz Doherty

Liz Doherty,审计委员会主席。自2019年起担任监事会成员;第一任期将于2023年届满。Reckitt Benckiser Group PLC前CFO兼董事会成员,Brambles Ltd前CFO,Delhaize Group、Nokia Corp.、SABMiller PLC和Dunelm Group PLC前非执行董事兼审计委员会成员。现任Novartis AG监事会成员兼审计委员会女主席,英国特许管理会计师协会Corbion N.V.研究员。曾任英国司法部和女王陛下法院和法庭事务处(英国)非执行委员会成员。现为Agrolimen SA的子公司GBfoods SA和Affinity Petcare SA的顾问。


Liz Doherty,Former CFO and board member of Reckitt Benckiser Group PLC, former CFO of Brambles Ltd, former non-executive director and audit committee member at Delhaize Group, Nokia Corp., SABMiller PLC and Dunelm Group PLC. Currently, member of the Supervisory Board and Chairwoman of the audit committee of Novartis AG and of Corbion N.V. Fellow of the Chartered Institute of Management Accountants. Former non-executive board member of the UK Ministry of Justice and of Her Majesty's Courts and Tribunals Service (UK) and advisor to GBfoods SA and Affinity Petcare SA, subsidiaries of Agrolimen.
Liz Doherty,审计委员会主席。自2019年起担任监事会成员;第一任期将于2023年届满。Reckitt Benckiser Group PLC前CFO兼董事会成员,Brambles Ltd前CFO,Delhaize Group、Nokia Corp.、SABMiller PLC和Dunelm Group PLC前非执行董事兼审计委员会成员。现任Novartis AG监事会成员兼审计委员会女主席,英国特许管理会计师协会Corbion N.V.研究员。曾任英国司法部和女王陛下法院和法庭事务处(英国)非执行委员会成员。现为Agrolimen SA的子公司GBfoods SA和Affinity Petcare SA的顾问。
Liz Doherty,Former CFO and board member of Reckitt Benckiser Group PLC, former CFO of Brambles Ltd, former non-executive director and audit committee member at Delhaize Group, Nokia Corp., SABMiller PLC and Dunelm Group PLC. Currently, member of the Supervisory Board and Chairwoman of the audit committee of Novartis AG and of Corbion N.V. Fellow of the Chartered Institute of Management Accountants. Former non-executive board member of the UK Ministry of Justice and of Her Majesty's Courts and Tribunals Service (UK) and advisor to GBfoods SA and Affinity Petcare SA, subsidiaries of Agrolimen.
Sanjay Poonen

Sanjay Poonen,2013年8月起,担任VMware的执行副总裁、终端用户计算机产品总经理。加入VMware之前,他在SAP AG工作了7年多;2012年4月至2013年7月,担任其总裁、平台解决方案与移动部企业官;此前,2010年11月至2012年3月,担任全球解决方案总裁;2008年6月至2009年9月,担任性能优化应用执行副总裁;2006年4月至2008年6月,担任分析部高级副总裁。他在科技行业有着20多年的经验,曾在Symantec 和Veritas担任过行政级别的职务,还在Alphablox、Apple、Microsoft Corporation担任过产品管理和工程方面的职务。


Sanjay Poonen,Former Chief Operating Officer at VMware and President at SAP. Currently CEO and President of Cohesity and member of the Board of Directors of Snyk.
Sanjay Poonen,2013年8月起,担任VMware的执行副总裁、终端用户计算机产品总经理。加入VMware之前,他在SAP AG工作了7年多;2012年4月至2013年7月,担任其总裁、平台解决方案与移动部企业官;此前,2010年11月至2012年3月,担任全球解决方案总裁;2008年6月至2009年9月,担任性能优化应用执行副总裁;2006年4月至2008年6月,担任分析部高级副总裁。他在科技行业有着20多年的经验,曾在Symantec 和Veritas担任过行政级别的职务,还在Alphablox、Apple、Microsoft Corporation担任过产品管理和工程方面的职务。
Sanjay Poonen,Former Chief Operating Officer at VMware and President at SAP. Currently CEO and President of Cohesity and member of the Board of Directors of Snyk.

高管简历

中英对照 |  中文 |  英文
Marnix van Ginneken

Marnix van Ginneken, 集团职责:法律和普通秘书。


Marnix van Ginneken,joined Philips in 2007 and became Head of Group Legal in 2010. In 2014, Marnix became Chief Legal Officer of Royal Philips and Member of the Executive Committee. In 2017 he was appointed to the Board of Management. He is responsible for driving ESG efforts across the company, including Sustainability. He is also responsible for Legal, Intellectual Property & Standards and Government & Public affairs. Since January 1, 2024 he is Chairman of the Board of the Philips Foundation. In 2011, he was appointed Professor of International Corporate Governance at the Erasmus School of Law in Rotterdam. Before joining Philips, Marnix worked for Akzo Nobel and as an attorney in a private practice.
Marnix van Ginneken, 集团职责:法律和普通秘书。
Marnix van Ginneken,joined Philips in 2007 and became Head of Group Legal in 2010. In 2014, Marnix became Chief Legal Officer of Royal Philips and Member of the Executive Committee. In 2017 he was appointed to the Board of Management. He is responsible for driving ESG efforts across the company, including Sustainability. He is also responsible for Legal, Intellectual Property & Standards and Government & Public affairs. Since January 1, 2024 he is Chairman of the Board of the Philips Foundation. In 2011, he was appointed Professor of International Corporate Governance at the Erasmus School of Law in Rotterdam. Before joining Philips, Marnix worked for Akzo Nobel and as an attorney in a private practice.
Abhijit Bhattacharya

Abhijit Bhattacharya,执行副总裁&首席财务官。自2015年12月起担任管理董事;担任的集团职位包括:Operating Model金融、资本结构、合并和收购、投资者关系,集资。


Abhijit Bhattacharya,first joined Philips in 1987 and has held multiple senior leadership positions across various businesses and functions in Europe, Asia Pacific and the US. Between 2010 – 2014, he was the Head of Investor Relations of Philips, and subsequently, CFO of Philips Healthcare, Philips' largest sector at the time. Prior to 2010, Abhijit was Head of Operations & Quality at ST-Ericsson, the joint venture of ST Microelectronics and Ericsson, and he was CFO of NXP's largest business group.
Abhijit Bhattacharya,执行副总裁&首席财务官。自2015年12月起担任管理董事;担任的集团职位包括:Operating Model金融、资本结构、合并和收购、投资者关系,集资。
Abhijit Bhattacharya,first joined Philips in 1987 and has held multiple senior leadership positions across various businesses and functions in Europe, Asia Pacific and the US. Between 2010 – 2014, he was the Head of Investor Relations of Philips, and subsequently, CFO of Philips Healthcare, Philips' largest sector at the time. Prior to 2010, Abhijit was Head of Operations & Quality at ST-Ericsson, the joint venture of ST Microelectronics and Ericsson, and he was CFO of NXP's largest business group.
Andy Ho

Andy Ho,1961年生,中国人。执行副总裁,飞利浦大中华区首席市场负责人。


Andy Ho, Born 1961 Chinese. Executive Vice President, Chief Market Leader of Philips Greater China.
Andy Ho,1961年生,中国人。执行副总裁,飞利浦大中华区首席市场负责人。
Andy Ho, Born 1961 Chinese. Executive Vice President, Chief Market Leader of Philips Greater China.
Roy Jakobs

罗伊·雅各布斯,1974年出生于荷兰/德国。执行副总裁,首席业务负责人个人健康。


Roy Jakobs,joined Philips in 2010 and has held various global leadership positions across the company, starting as Chief Marketing & Strategy Officer for Philips Lighting. In 2012, he became Market Leader for Philips Middle East & Turkey, leading the Healthcare, Consumer, and Lighting businesses out of Dubai. Subsequently, he became Business Leader of Domestic Appliances, based in Shanghai, in 2015. In 2018, Roy joined the Executive Committee as Chief Business Leader of the Personal Health businesses and in early 2020 he started as Chief Business Leader of Connected Care. Prior to his career at Philips, he held various management positions at Royal Dutch Shell and Reed Elsevier.
罗伊·雅各布斯,1974年出生于荷兰/德国。执行副总裁,首席业务负责人个人健康。
Roy Jakobs,joined Philips in 2010 and has held various global leadership positions across the company, starting as Chief Marketing & Strategy Officer for Philips Lighting. In 2012, he became Market Leader for Philips Middle East & Turkey, leading the Healthcare, Consumer, and Lighting businesses out of Dubai. Subsequently, he became Business Leader of Domestic Appliances, based in Shanghai, in 2015. In 2018, Roy joined the Executive Committee as Chief Business Leader of the Personal Health businesses and in early 2020 he started as Chief Business Leader of Connected Care. Prior to his career at Philips, he held various management positions at Royal Dutch Shell and Reed Elsevier.
Bert van Meurs

Bert van Meurs,1961年出生于荷兰。执行副总裁,图像引导治疗首席业务负责人,共同负责诊断和治疗。


Bert van Meurs, Born 1961 Dutch. Executive Vice President, Chief Business Leader Image Guided Therapy and jointly responsible for Diagnosis & Treatment.
Bert van Meurs,1961年出生于荷兰。执行副总裁,图像引导治疗首席业务负责人,共同负责诊断和治疗。
Bert van Meurs, Born 1961 Dutch. Executive Vice President, Chief Business Leader Image Guided Therapy and jointly responsible for Diagnosis & Treatment.
Deeptha Khanna
暂无中文简介

暂无英文简介
暂无中文简介
暂无英文简介
Edwin Paalvast
暂无中文简介

暂无英文简介
暂无中文简介
暂无英文简介
Shez Partovi
暂无中文简介

暂无英文简介
暂无中文简介
暂无英文简介
Willem Appelo
暂无中文简介

暂无英文简介
暂无中文简介
暂无英文简介
Jeff DiLullo
暂无中文简介

暂无英文简介
暂无中文简介
暂无英文简介
Heidi Sichien
暂无中文简介

暂无英文简介
暂无中文简介
暂无英文简介
Steve C de Baca
暂无中文简介

暂无英文简介
暂无中文简介
暂无英文简介
Julia Strandberg
暂无中文简介

暂无英文简介
暂无中文简介
暂无英文简介